Proto-oncogene c-myc is implicated in proliferation of mammalian cells. Although c-Myc protein has been demonstrated to function as a transcription factor recognizing an E-box (CACGTG) element, few c-mycregulated genes have been identi®ed and the speci®c role of c-myc is still unclear. RCC1 is necessary for mammalian cells to proliferate. Four CACGTG elements exist within 1.3 kb downstream of the major transcription start site for the human RCC1 gene in HeLa cells. Stimulation of HeLa cells with serum increased c-myc expression and RCC1 expression. Therefore the relationship between the expression of RCC1 and c-myc was investigated. Rat 3Y1 cells overexpressing c-myc contained about twice as much RCC1 mRNA as control cells. When a chimeric protein comprised of c-myc and the estrogen binding domain of estrogen receptor was activated by addition of 4-hydroxytamoxifen (OHT), expression of RCC1 mRNA increased twofold. To examine whether c-Myc functions through the CACGTG elements, a DNA fragment of RCC1 intron 4, exon 5 and part of intron 5 was joined to ®re¯y luciferase cDNA to construct a reporter plasmid. In transient expression experiments using HeLa cells, co-transfection with c-myc stimulated the luciferase activity up to 2.5-fold in a dose-dependent manner. When the CACGTG elements in the reporter plasmid were destroyed, stimulation by c-myc was not observed. The four CACGTG elements did not contribute equally to the stimulation by c-myc. Gel retardation experiments suggest that c-Myc with Max binds to the CACGTG elements in the context of the RCC1 gene sequence in vitro. These results indicate that c-Myc can regulate expression of RCC1 through the E-box elements.
Introduction
The proto-oncogene c-myc is implicated in proliferation of mammalian cells (Kelly, 1986; LuÈ scher and Eisenman, 1990; DePinho et al., 1991; Marcu et al., 1992) . c-myc is required for cells to progress through G 1 -phase (Kelly, 1986; Marcu et al., 1992) and from S to G 2 /M phase of the cell cycle (Shibuya et al., 1992) . However, the precise roles of c-myc in cell cycle progression are still unclear. The c-myc gene product, c-Myc protein, associates with a partner Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) . The heterodimer of c-Myc and Max elevates expression from arti®cial promoters (Amati et al., 1992; Kretzner et al., 1992) through binding to E-box (CACGTG) elements (Marcu et al., 1992; Prendergast and Zi, 1992) . It has been recently reported that a few genes involved in cell cycle progression can be directly controlled by c-Myc protein through CACGTG elements, including the ornithine decarboxylase (ODC) genes (Bello-Fernandez et al., 1993; PenÄ a et al., 1993) and the prothymosin a gene (Gaubatz et al., 1994) . However, upregulation of these genes can only partially explain the role of c-myc in cell proliferation. Identifying additional genes regulated by c-myc will help elucidate the speci®c roles of c-myc in cell proliferation.
The RCC1 (regulator of chromosome condensation-1) gene was discovered in a temperature sensitive BHK 21/13 cell line, tsBN2, that carries a single point mutation in RCC1 (Nishimoto et al., 1978; Uchida et al., 1990) . tsBN2 cells accumulate in the G 1 -phase of the cell cycle when asynchronous cultures are shifted to a non permissive temperature (Nishimoto et al., 1978) . When synchronized cultures in S-phase are shifted to a non permissive temperature, tsBN2 cells enter mitosis prematurely (Nishimoto et al., 1978; Nishitani et al., 1991) . These results indicate that the RCC1 gene is necessary for mammalian cells to progress through G 1 and for proper progression from S to G 2 /M phase. Schizosaccharomyces pombe cells carrying temperature sensitive alleles of PIM1, the RCC1 homologue, also undergo premature mitosis when shifted to a nonpermissive temperature (Matsumoto and Beach, 1991) . The RCC1 gene product is a chromatin bound protein (Ohtsubo et al., 1989) that acts as a guanine nucleotide exchange factor for Ran, a ras-related nuclear GTPase (Bisho and Ponstingl, 1991a,b) and is required for many important nuclear functions, including nuclear transport of protein (Moor and Blobel, 1993; Tachibana et al., 1994; Schlenstedt et al., 1995) and RNA export from the nuclei (Kadowaki et al., 1993; Amberg et al., 1993) .
In the sequence of the human RCC1 gene (Furuno et al., 1991) , we noticed four CACGTG elements, potential Myc binding sites (MB sites) (Figure 1 ), within 1.3 kb downstream of the major transcription start site. We investigated whether the expression of RCC1 is controlled by c-myc. When ectopic c-myc was expressed, expression of RCC1 increased. Furthermore, transient expression experiments with reporter plasmids containing part of the RCC1 gene sequence suggest that c-myc can transactivate the expression of RCC1 through the CACGTG elements downstream of the transcription start sites.
Results

Structure of the RCC1 gene
The human RCC1 gene has 14 exons and encodes RCC1 protein from exon 6 to exon 14 (Furuno et al., 1991; see Figure 1 ). Two types of cDNAs have been isolated. One cDNA encodes exon 1 to exon 14, but exon 5 is skipped. The other one encodes exon 5 to exon 14. The major transcription start site was found to be upstream of exon 5 rather than exon 1 (Furuno et al., 1991) , suggesting that transcription from exon 5 is physiologically important. CACGTG elements can function as a target sequence for transactivation of gene expression by c-Myc. Some c-myc regulating genes, including the ODC genes (Bello-Fernandez et al., 1993; PenÄ a et al., 1993) and the prothymosin a gene (Gaubatz et al., 1994) , have CACGTG elements downstream of the transcription start site. Four CACGTG elements are located within 1.3 kb downstream of the transcription start site (Figure 1 ). When serum-starved HeLa cells were stimulated with serum, expression of c-myc increased steeply at 1 h with a peak expression at 2 h and remained elevated through 8 h. Elevation of RCC1 expression was low compared to that of c-myc at 1 h after serum stimulation and accumulation of RCC1 continued to increase through 8 h (Figure 2 ). These results are consistent with a model in which high-level expression of c-myc is related to the elevation of RCC1 expression, although other factors may be involved in the stimulation of RCC1 expression. These observations, in combination with the presence of potential c-Myc binding sites in the RCC1 gene, suggest that c-myc may control expression of RCC1.
c-myc stimulates expression of RCC1 in cells
To study eects of c-myc on RCC1 expression we established cells that express high levels of c-Myc protein. A rat ®broblast cell line, 3Y1, was cotransfected with human c-myc cDNA under a constitutive promoter and a selectable marker plasmid, yielding 3Y1myc cells. The selected population, rather than individual clones, was used to reduce the eect of clonal variation. Control 3Y1CDM8 cells were produced by the same procedure using a plasmid lacking the c-myc sequence. Expression of c-Myc protein was analysed by Western blotting and indirect immuno¯uorescence staining with anti-c-Myc protein antibody. Figure 3a shows high levels of c-Myc protein in cell lysates from 3Y1myc cells compared to 3Y1CDM8 cells. In addition, stronger staining for c-Myc protein was observed in almost all nuclei of 3Y1myc cells (Figure 3b ). High expression of human c-myc mRNA was also observed in 3Y1myc cells (Figure 3c ). The expression of RCC1 mRNA was stimulated in 3Y1myc cells, while expression of control actin mRNA was not (Figure 3c ). Quantitative analysis revealed that 3Y1myc cells express about twice as much RCC1 mRNA as 3Y1CDM8 cells. To further study c-myc stimulation of RCC1 expression, the estrogen-inducible MYC system (Eilers et al., 1989) was used. The chimeric protein MycER consists of human c-myc and the estrogen binding domain of the human estrogen receptor (Figure 4a ). The MycER protein is speci®cally activated by 4-hydroxytamoxifen (OHT) (Eilers et al., 1991) . A 3Y1 cell line expressing MycER protein (3Y1ME-7) was established. 3Y1 cell lines, 3Y1mME-13 and 3Y1mME-25, that express mutant MycER chimeric protein were also established (Figure 4a ). 3Y1mME-13 expresses the mutant c-Myc (D41 ± 178)ER protein that lacks a large part of the transactivating domain (TAD). 3Y1mME-25 expresses the mutant c-Myc (D393 ± 439)ER that lacks a large part of the helix ± loop ± helix leucine zipper domain (HLHLZ), therefore the protein cannot dimerize with Max. 3Y1ME-7, 3Y1mME-13 and 3Y1mME-25 express comparable levels of the MycER chimeric proteins (Figure 4b) .
Expression of RCC1 mRNA was investigated at various times after activation of MycER by addition of OHT to growing cells. As shown in Figure 4c to increase. At 6 h, 3Y1ME-7 cells treated with OHT contained about twice as much as RCC1 mRNA as untreated cells. Expression of ODC was also stimulated by OHT, and the extent and time course of the stimulation were similar to those for RCC1 (Figure 4c ). Expression of actin mRNA was not increased by OHT treatment. No stimulation of RCC1 or ODC expression by OHT was observed in 3Y1mME-13 (Figure 4c ) or 3Y1mME-25 cells (data not shown).
Binding of c-Myc protein to the CACGTG elements in the human RCC1 gene in vitro
We designated the CACGTG elements from 12300 to 12305, from 12702 to 12707, from 13251 to 13256 and from 13452 to 13457 as MB4, MB5, MB6 and MB7, respectively (Figure 1) . In a gel retardation experiment using radiolabeled MB4 oligonucleotide, the combination of the recombinant Myc and Max produced shifted band, but neither c-Myc nor Max alone did under the experimental conditions used ( Figure 5a ). The band was supershifted in the presence of anti cMyc monoclonal antibody or anti Max protein rabbit polyclonal antibody. The intensity of the shifted band was decreased when an excess of unlabeled MB4 oligonucleotide was added, while it was barely affected by addition of an excess of unlabeled mutant MB4 oligonucleotide (mMB4) in which CACGTG was changed to CACCTG ( Figure 5b ). The results indicate that c-Myc and Max speci®cally recognize the CACGTG element in MB4.
Excess unlabeled MB5, MB6 or MB7 oligonucleotides in the reaction mixture decreased the band intensity more than unlabeled mutant mMB5, mMB6 or mMB7 oligonucleotides, which contain CACCTG instead of CACGTG, suggesting that complex of cMyc and Max also binds MB5, MB6 and MB7 through CACGTG elements.
c-myc stimulates expression from an RCC1 genomic DNA fragment in transient expression experiments
To test whether promoter activity really exists around exon 5, an RCC1 genomic DNA fragment including intron 4, exon 5 and part of intron 5 was joined to ®re¯y luciferase cDNA to construct a reporter plasmid, pHgRCC1-II(W)luci (Figure 1 ). Transient expression assays in HeLa cells indicated that the DNA fragment has promoter activity (data not shown; see Figure 6 ).
To test whether the expression of the RCC1 gene is aected by c-myc, the reporter plasmids were cotransfected with various amounts of c-myc expression plasmid. Luciferase activities were measured 30 h after transfection of HeLa cells. When pHgRCC1-II(W)luci was co-transfected with a c-myc expression plasmid, the luciferase activity was increased up to about 2.5-fold by c-myc in a dose dependent manner (Figure 6a ). This stimulation is comparable to that observed in cell lines highly expressing c-Myc (Figures 3 and 4) . Expression from pHgRCC1-II(mutant)luci, whose four CACGTGs were all mutated to CACCTG, was not increased by c-myc (Figure 6a ). These results indicate that c-myc stimulates the expression of pHgRCC1-II(W)luci through the CACGTG elements.
To determine which MB sites are functional in the cells, reporter plasmids pHgRCC1-II(m4)luci, pHgR-CC1-II(m5)luci, pHgRCC1-II(m6)luci and pHgRCC1-II(m7)luci were constructed, each with a dierent CACGTG element mutated to CACCTG. As shown in Figure 6b , mutation of MB4 did not aect c-myc stimulation, and mutation of MB7 had little eect. On the other hand, mutation of MB5 or MB6 decreased the extent of c-myc stimulation. This suggests that cmyc functions through MB6 and MB5. To con®rm these results reporter plasmids with double mutations in MB6 and MB7 (pHgRCC1-II(m67)luci), MB5 and MB7 (pHgRCC1-II(m57)luci), MB5 and MB6 (pHgRCC1-II(m56)luci), or MB4 and MB7 (pHgR-CC1-II(m47)luci) were constructed. As shown in Figure  6c , double mutations in MB6 and MB7, or in MB5 and MB7 decreased the c-myc stimulation, but did not completely abolish the response to c-myc. On the other hand, mutation in both MB5 and MB6 completely abolished c-myc stimulation. Double mutations in MB4 and MB7 had no eect on c-myc stimulation.
Discussion
c-myc regulates the expression of RCC1 through CACGTG elements
We presented evidence from three systems that c-myc can regulate the expression of RCC1. High expression of c-myc increased the expression of RCC1 mRNA in growing 3Y1 cells. Stimulation of the expression of RCC1 mRNA by c-myc was also observed when c-Myc protein was activated in MycER chimeric protein 3Y1 3Y1ME-7 3Y1mME-13 3Y1mME-25
Mr(kDa) Expression of MycER chimeric proteins in 3Y1ME-7, 3Y1mME-13 and 3Y1mME-25. The chimeric proteins were detected by Western blotting using anti c-Myc rabbit polyclonal antibody. 3Y1ME-7 expresses wild type MycER protein, 3Y1mME-13 expresses Myc(D41 ± 178)ER protein, and 3Y1mME-25 expresses Myc(D393 ± 439)ER protein. Three cell lines express the chimeric proteins at comparable levels. (c) Stimulation of RCC1 and ODC expression by activation of MycER at various times after actively growing 3Y1ME-7 cells (i, ii, iii) or 3Y1mME-13 cells (iv, v, vi) were treated with 1 mM OHT (*) or mock treated (*), RNA was isolated and analysed for RCC1 (i and iv), ODC (ii and v) and actin (iii and vi) mRNA and quanti®ed as described in Materials and methods. Expression of RCC1 and ODC was increased up to twofold by activation of MycER. Four independent experiments gave essentially the same results, showing that the increase is reproducible reported a 3.5-fold induction of ODC promoter activity by c-Myc (Tobias et al., 1995) , while 100-fold induction was reported by another group (BelloFernandez et al., 1993) . Two-to threefold inductiond (Gaubatz et al., 1994) and 10-fold induction (Desbarats et al., 1996) of the prothymosin a promoter by c-myc were reported. We observed up to 2.5-fold induction of RCC1 promoter activity by c-myc in co-transfection experiments, which is similar to the degree of stimulation of the endogenous RCC1 gene in 3Y1ME-7 cells when MycER was activated by OHT. When the CACGTG elements in the reporter plasmid were destroyed, stimulation of reporter gene expression by c-myc was abolished. c-Myc protein binds to the four CACGTG elements, but not to mutated forms (CACCTG) in vitro. Together, these results indicate 32 P-labeled MB4 oligonucleotide plus a 400-, 1600-fold excess of the unlabeled MB4, MB5, MB6, MB7 oligonucleotides, or plus oligonucleotide in which the CACGTG sequence was replaced with CACCTG (mMB4, mMB5, mMB6 and mMB7) and then analysed by gel retardation as described in Materials and methods that the proto-oncogene c-myc regulates expression of the well-characterized cell cycle gene RCC1 through Ebox CACGTG elements.
Through which CACGTG elements does c-Myc act?
The four CACGTG elements were not equivalent. Mutations of both MB5 and MB6 eliminated stimulation by c-myc in the co-transfection experiments, despite the presence of the two CACGTG elements at MB4 and MB7. The presence of CACGTG elements is not sucient for transactivation by c-Myc and additional factors must be involved.
The binding of c-Myc protein to the CACGTG elements in cells may be aected by other transcription factors. TFE3 (Beckman et al., 1990) , USF (Gregor et al., 1990) and TFEB (Carr and Sharp, 1990) bind to CACGTG elements to transactivate gene expression. Mad1 (Ayer et al., 1993 , Mxi-1 (Zervos et al., 1993; Schreiber-Agus et al., 1995) , Mad-3 and Mad-4 (Hurlin et al., 1995) form heterodimers with Max that bind to CACGTG elements and exert negative eects on gene expression. Such factors may aect interaction of c-Myc with CACGTG elements.
Negative control of binding of c-Myc to a CACGTG element by the transcription factor AP-2 through a GCCNNNGGC adjacent to the Myc protein binding sequence has been reported (Gaubatz et al., 1995) . Although there is no AP-2 sites near any of the four CACGTG sites of the RCC1 gene, it is possible that some factor or factors that recognize other sites may aect the binding of c-Myc.
When sequences around the CACGTG elements are compared some conserved nucleotides can be detected at 74, +7 and +11 relative to the ®rst nucleotide in the CACGTG element (Figure 7) . G/C at 74 may be important, because in all cases of nonfunctional CACGTG elements these nucleotides were mutated to A (Figure 7b ). Substitutions were also observed at +7 and +11 in some cases of the nonfunctional CACGTGs. Investigation of c-Myc protein binding to the CACGTG elements in vivo and studies of the eect of c-myc on systematic mutants of the reporter plasmids will help to resolve whether nucleotides at these positions play an important role.
c-Myc had been demonstrated to function through a CACGTG element upstream of transcription start site in arti®cial promoters (Amati et al., 1992; Kretzner et al., 1992) . However among the genes known to be regulated by c-myc, many have eective CACGTG elements downstream of the transcription start sites. Two eective CACGTGs are located at +232 to +237 and +272 to +277 in the mouse ornithine decarboxylase (ODC) gene (Bello-Fernandez et al., 1993) , one at +70 to +75 in the mouse p53 gene (Reisman et al., , one at +105 to +110 in ECA39 (Benvenisty et al., 1992) and one at +1.6 kb in the rat prothymosin a gene (Gaubatz et al., 1994) . As shown here, the human RCC1 gene has eective downstream CACGTG elements at +516 to +521 and +1065 to +1070. Very recently, cdc25A and MrDb were reported to be targets of c-myc and have two and one eective CACGTG elements downstream of the transcription start sites (Galaktionov et al., 1996; Grandori et al., 1996) . Why do the genes identi®ed as myc-regulated genes have CACGTG elements downstream of the transcription start site, but not upstream? Recently it was reported that USF, another transcription factor that recognizes CACGTG, eciently stimulates expression from promoters having CACGTG elements upstream but not downstream of the transcription start site (Tobias et al., 1995; Desbarats et al., 1996) . Because USF is a highly abundant protein, it may be relatively dicult for c-Myc to aect the expression from promoters having CACGTG elements upstream of the transcription start site, compared to those having CACGTG elements downstream.
Possible eect of elevated expression of RCC1 by c-myc
Recently, it was suggested that the ability of c-myc to activate the gene expression through a CACGTG element in a distal rather than a proximal position may be important for cell transformation (Desbarats et al., 1996) . The RCC1 gene has the functional CACGTG elements 0.5 and 1 kb distal from the transcription start site and RCC1 is clearly related to the cell cycle progression. Thus the activation of the RCC1 gene expression by c-myc may be related to cell transformation by c-myc. c-myc is required for the progression of G 1 , and high expression of c-myc shortens the duration of G 1 and accelerates enter into S-phase (Karn et al., 1989) . Because RCC1 protein is required for DNA replication (Dasso et al., 1992 (Dasso et al., , 1994 Ren et al., 1993) , elevated expression of RCC1 by c-myc may be related to the rapid enter into S-phase. RCC1 protein is required for other important nuclear functions including RNA processing (Kadowaki et al., 1993; Cheng et al., 1995) , RNA export from the nuclei (Kadowaki et al., 1993; Amberg et al., 1993) and nuclear transport of proteins (Moor and Blobel, 1993; Tachibana et al., 1994; Schlenstedt et al., 1995) . Although these functions do not seem to be directly related to the cell cycle, all of them are related to synthesis and localization of newly synthesized proteins. Because many protein factors, some of which are nuclear proteins like G 1 -cyclins, are involved in cell cycle progression, elevated expression of RCC1 may aect the amount of newly synthesized and properly localized protein, and therefore aect cell cycle progression. cmyc has also been shown to play a role in S to G 2 /M transition (Shibuya et al., 1992) , although the molecular mechanism is not clear. Because RCC1 plays a crucial role in S to G 2 /M transition in mammalian cells (Nishimoto et al., 1978) and Schizosaccharomyces pombe (Matsumoto and Beach, 1991) , control of RCC1 expression of c-myc may be related to the S to G 2 /M transition.
Materials and methods
Plasmids
Plasmids encoding c-myc The 1.6 kb BamHI fragment of human c-myc cDNA from pTmyc1 (a kind gift from Dr S Ishii) was inserted into the BamHI site of Bluescript KS(+)(Stratagene La Jolla, CA). The resulting plasmid was named pTc-myc/BS. To delete the 5'-noncoding region of c-myc cDNA, which might contain a regulatory sequence, the cDNA encoding the N-terminal portion of c-myc was ampli®ed by PCR with CTCCTCGAG-GATGCCCCTCAACGTTA (including the initiation ATG codon) and AGCTCGGTCACCATCTCCAGC-TGGT (including the BstEII site) as primers, and the ampli®ed 324 bp fragment was cleaved with XhoI and BstEII and ligated with pTc-myc/BS cut with XhoI and BstEII to produce pc-myc/BS. The 1.6 kb XhoI (blunted with Klenow Enzyme)-XbaI fragment of pc-myc/BS was inserted into pCDM8 (Invitrogen Corp, Dan Diego, CA) which had been digested with HindIII (blunted with Klenow Enzyme) and XbaI. The resulting plasmid, pcmyc/CDM8, contains only a G from 5'-noncoding sequence of c-myc cDNA. To produce a recombinant polypeptide containing the c-myc sequence from Ile 49 to the C terminal in E coli, the 1.5 kb EcoRV ± BamHI fragment of pc-myc/ BS was inserted into the NcoI (blunted with Klenow Enzyme) and BamHI sites of pET11d (Novagen), an E coli expression vector to produce pc-myc/PET. GST-c-Myc fusion protein was expressed in E coli using pETGSTMyc (a kind gift of Dr Obinata).
To construct a cDNA encoding a chimeric MycER protein, the stop codon in pTc-myc/BS was removed. The cDNA encoding the C-terminal portion of c-myc was ampli®ed by PCR with 5'AGGCCCCCAAGGTAGTTA-TCCTT (including StyI site in human c-myc cDNA) and 5'-TCTCGAGGCACAAGAGTTCCGTA (removing the stop TAA codon and adding an XhoI site) as primers. The ampli®ed 156 bp fragment was inserted into the EcoRV site of Bluescript KS(+) to produce pTc-c-myc/BS. The 1.2 kb XhoI (blunted with Klenow Enzyme)-StyI fragment of pTca b Figure 7 Comparison of CACGTG elements within RCC1 (Furuno et al., 1991) , ODC (Bello-Fernandez et al., 1993) , prothymosin a (PT) (Gaubatz et al., 1994) , ECA39 (Benvenisty et al., 1992) , p53 (Ronen et al., 1991) , cdc 25A (Galaktionov et al., 1996) and MrDb (Grandori et al., 1996) . Functional elements are listed in a and nonfunctional elements in b. Conserved nucloetides in the functional elements are shown in the line labeled`consensus' myc/BS was inserted into 3.1 kb EcoRI (Blunted with Klenow Enzyme)-StyI fragment of pTc-c-myc/BS to produce pTc-mycX/BS. The 920 bp EcoRI (blunted with Klenow Enzyme and ligated with XhoI linker) -XhoI fragment of pBSKS-ER (Nakabeppu et al., 1993) was inserted into the XhoI site of pTc-mycX/BS to produce pTc-mycer/BS. To introduce stop codons at the end of the cDNA, oligonucleotides 5'TCGATAGGTAGGTAGGGCC and 5'-CTACC-TACCTA were annealed at 708C for 3 min and ligated to the ApaI and SalI fragment of pTc-mycER/BS to produce pTc-mycerS/BS. The 2 kb SmaI and ApaI fragment of pTcmycerS/BS was inserted into the 4 kb BamHI (blunted with Klenow Enzyme and ligated with ApaI linker) -XbaI (blunted with Klenow Enzyme) fragment of MSV LTR-c-mos xe (Okazaki et al., 1992) to produce pMLmycer in which cmycer is driven by the MSV-LTR promoter. To construct a cDNA encoding a chimeric mutant Myc (D41 ± 178)-ER protein, the 131 bp HindIII (blunted with Klenow Enzyme)-PstI fragment of pc-myc/CDM8 was inserted into the 3.8 kb SmaI-PstI fragment of pTc-mycX/BS to produce pcmyc(D41 ± 178)X/BS. The 0.9 kb EcoRI and NotI fragment was inserted into the 3.8 kb of pTc-mycerS/BS to produce pcmyc(D41 ± 178)erS/BS. To introduce ApaI site at BamHI site of MSV LTR-c-mos xe , MSV LTR-c-mos xe was digested with BamHI, blunted with Klenow fragment and was inserted ApaI linker (5'-GGGGCCCC) to produce pMLmosA. The 0.6 kb XbaI ± ApaI fragment of pMLmycer was inserted into 4.6 kb XbaI ± ApaI fragment of pMLmosA to produce pMLDerS. The 1.2 kb XbaI fragment of pc-myc(D41 ± 178)erS/BS was inserted into the 4.4 kb XbaI ± ApaI fragment of pMLDerS to produce pMLmyc(D41 ± 178)er. To construct a cDNA encoding a chimeric mutant Myc (D393 ± 439)ER protein, the 1.2 kb NotI ± StyI (blunted with Klenow Enzyme) of pTc-mycX/BS was inserted into the 4 kb NotI ± EcoRI (blunted with Klenow Enzyme) of pTc-mycerS/BS to produce pc-myc(D393 ± 439)erS/BS. The 1.5 kb XbaI fragment of pc-myc(D393 ± 439)erS/BS was inserted into the 4.4 kb XbaI ± ApaI fragment of pMLDerS to produce pMLmyc(D393 ± 439)er. The plasmid constructions were con®rmed by DNA sequencing (Sanger et al., 1977) .
Plasmids encoding max The DNA fragment encoding human max was ampli®ed by PCR using oligonucleotides, 5'-TGGGAAGCTTGAAATGAGCGATAACGA and 5'-AAGCTCCGGATGGAGGCCAGCTAAGCCAC-TCGGGGCAGG from HeLa cell cDNA library in lZAP (a kind gift from Dr Kohno). Using this DNA fragment, human max cDNA was isolated from a HeLa cell cDNA library in lZAP. The 1.7 kb HindIII ± NotI fragment of human max cDNA was inserted into pCDM8 which had been digested with HindIII and NotI to produce pmax/ CDM8. To express GST-Max fusion protein, the cDNA encoding Max protein was ampli®ed by PCR with 5'-CGCGGGATCCAAATGAGCGATAACGATGACATCG (adding BamHI site) and 5'-CGCGAATTCGCTTAG-CTGGCCTCCATCCGG (adding EcoRI site) as primers. The ampli®ed 0.4 kb bp fragment was inserted into the 4.5 kb EcoRI ± BamHI fragment of pGEX-3X (Pharmacia Biotech) to produce pGEX-max. The fusion protein was produced according to the instruction manuals of Pharmacia Biotech.
Reporter plasmids having RCC1 genomic DNA fragments The 3.4 kb SalI ± pPUMI (blunted with Klenow enzyme) of the human RCC1 gene, which extends from the promoter region to part of 3rd exon (Furuno et al., 1991) , was inserted into the 5 kb XhoI ± HindIII fragment of pUHC 13-3 (Gossen and Bujard, 1992) to produce pgRCC1-I(W)luci. To introduce HindIII site in pgRCC1-I(W)luci, HindIII linker (CCCAAGCTTGGG) was inserted into pgRCC1-I(W)luci, which had been digested with AatII and blunted with Klenow fragment, to produce pHgRCC1-I(W)luci. The 4.2 kb EcoRI ± Bst1107I fragment of human RCC1 genomic DNA, which includes intron 4, exon 5 and part of intron 5, was inserted into Bluescript ks(+), which had been digested with EcoRI and SmaI, to produce pgRCC1-II/BS. The 2.8 kb EcoRI ± PvuII fragment of pgRCC1-II/BS was inserted into pHgRCC1-I(W)luci, which had been digested with HindIII and Bst1107I, to produce pHgRCC1-II(W)luci. The 1.3 kb EcoRI ± PstI, 264 bp PstI ± SstII, 297 bp XhoI ± BamHI, 1 kb BamHI ± BamHI fragment of pgRCC1-II/BS, which include MB4, MB5, MB6 and MB7, respectively, were inserted into Bluescript ks(+) to produce pMB4/BS, pMB5/BS, pMB6/ BS, pMB7/BS. To introduce mutation in pMB5/BS, a double stranded oligonucleotide prepared from 5'-CTGAAGCCCGGAGGCAGGAAGGCGCGGTGCGGG-CTCGCGATTCCCCGGCCCCGC and 5'-GGGGCCGG-GGAATCGCGAGCCCGCACCGCGCCTTCCTGCCTC-CGGGCTTCAG was inserted into pMB5/BS, which had been digested with PmaCI and SstII, to produce pmMB5/ BS where CACGTG was mutated to CACCTG. To introduce a mutation in pMB6/BS, a double stranded oligonucleotide prepared from 5'-CTGTGACTTGTGTG-CCCTAGCAGAAGTTGAGTGTGTGGGGTGTTTACG-GGGAAGCCCTCAGGGG and 5'-GATCCCCCTGAG-GGCTTCCCCGTAAACACCCCACACACTCAACTTCT-GCTAGGGCACACAAGTCACAG was inserted into pMB6/BS, which had been digested with PmacI and BamHI, to produce pmMB6/BS. To introduce a mutation in pMB4/BS, the double stranded oligonucleotide of 5'-CCATGGAATTCACGC and 5'-GCGTGAATTCCATGG was inserted into pMB4/BS, which had been digested with PmaCI. The resulting plasmid was digested with NcoI and MluI, blunted with Mung Bean Nuclease and Klenow fragment, and self-ligated to produce pmMB4/BS. The same procedure was used to produce pmMB7/BS. The 1 kb BamHI fragment of pmMB7/BS was inserted into the 4.7 kb pgRCC1-II/BS to produce pgRCC1-II(m7)/BS. The 2.8 kb EcoRI ± PvuII fragment of pgRCC1-II(m7)/BS was inserted into pHgRCC1-I(W)luci, which had been digested with HindIII and Bst1107I, to produce pHgRCC1-II(m7)luci. To construct the reporter plasmids having mutant MB sites, the 1.3 kb EcoRI ± PstI, 264 bp PstI ± SstII and 297 bp XhoI ± BamHI fragment of pmMB4/BS, pmMB5/BS and pmMB6/BS, respectively, were inserted into pHgRCC1(W)luci or pHgRCC1(m7)luci, which had been digested appropriate restriction endonucleases.
Other plasmids pRSVlacZ, which expresses b-galactosidase under RSV promoter was a kind gift of Dr Okazaki. pActHyg, which contains a hygromycin resistance gene under control of an actin promoter, was a kind gift from Dr M Nakanishi.
Cell culture and establishment of cells
A rat ®broblast cell line 3Y1 (Kimura et al., 1975; Yamashita et al., 1980) was grown in Dalbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). To establish cells highly expressing cmyc, 3Y1 cells were transfected with 20 mg of pc-myc/ CDM8 and 0.4 mg of pActHyg by the calcium-phosphate method (Chen and Okayama, 1988) . The cells were cultured for 2 weeks in selection medium (DMEM supplemented with 10% FBS and 200 mg/ml hygromycin) to select stable transfectants. Cells were stored frozen in LN2. 3Y1 cells were also transfected with 20 mg of pCDM8 and 0.4 mg of pActHyg to obtain the control 3Y1CDM8 cells. To establish 3Y1 cells expressing MycER chimeric protein, 3Y1 cells were transfected with 20 mg of pMLmycer and 0.4 mg of pActHyg and transformants were selected as described above. Individual clones were isolated and the expression of MycER protein in the cells was detected by Western blot analysis using anti c-Myc protein antibody. Clone 3Y1ME-7, which expresses a high level of the chimeric protein, was used in the work described here. Clone 3Y1mME-13 and 3Y1mME-25, produced by transfection with pMLmyc(D41 ± 178)er or pMLmyc(D393 ± 439)er, were isolated in the same manner and express the chimeric protein at levels similar to that of 3Y1ME-7. When the eect of 4-hydroxytamoxifen (OHT) was studied, cells were cultured in phenol red-free DMEM supplemented with charcoal-treated FBS (Eckert and Katzenellenbogen, 1982) .
Antibodies, Western blot analysis and indirect immuno¯uorescence staining
The portion of human c-Myc protein from Ile 49 to the carboxyl terminal end was expressed using pc-myc/PET in E coli BL21 (DE3) (Novagen) and isolated by SDS ± PAGE as described previously (Tsuneoka et al., 1988) . Rabbits were immunized with the recombinant polypeptide. The antibody was puri®ed from the rabbit serum using Sepharose 4B conjugated with the recombinant c-Myc polypeptide. Western blotting was performed essentially as described previously (Tsuneoka and Mekada, 1992) using anti c-Myc protein antibody, except that the signals were detected by a chemiluminescent substrate system (ECL) (Amersham Ltd). c-Myc protein was visualized by indirect immuno¯uorescence staining as described previously (Tsuneoka and Mekada, 1992) using anti c-Myc protein antibody, except that the protein was detected using biotinylated anti rabbit IgG and Cy3-conjugated streptavidin (Pierce Chemical Co). Anity puri®ed anti Max was purchased from Oncogene Science, and anti c-Myc monoclonal antibody (C-8) was purchased from Santa Cruz Biotechnology.
Preparation of probe DNAs
The DNA probes for RCC1, ODC, c-myc and b-actin were prepared as follows: RCC1, 1.7 kb BamHI fragment excised from pcD40, which contains human RCC1 cDNA (Ohtsubo et al., 1987) ; ODC, 2.2 kb EcoRI fragment from pODC-2, which contains rat ODC cDNA (Wen et al., 1989) ; c-myc, 1.6 kb HindIII ± XbaI fragment from pc-myc/ CDM8 (described in this paper); b-actin, 2.0 kb BamHI ± PvuII fragment from pbActA1, in which a human b-actin gene is inserted into pBR322 (a kind gift of Dr M Nakanishi).
RNA preparation and Northern blot analysis
RNA was isolated from cells by the acid guanidinium thiocyanate-phenol-chloroform extraction method described previously (Chomczynski and Sacchi, 1987) . RNA was electrophoresed in a gel containing formaldehyde, transferred to hybond-N (Amersham Ltd) and was detected with 32 P-labeled cDNA probes as described previously (Sambrook et al., 1989) . Probes were labeled with [a-32 P]dCTP using a Multiprime labeling kit (Amersham Ltd). The results were quanti®ed using a BAS2000 image analyzer (Fuji Photo Film Co).
Transient expression assay using luciferase
HeLa cells were grown in DMEM supplemented with 10% FBS. For transfection, 1610 5 of HeLa cells were plated into a 35 mm dish and cultured for 20 ± 24 h. Transfections were carried out by the calcium-phosphate method (Chen and Okayama, 1988) with 1 mg of the reporter plasmids and 3 mg of pRSVlacZ as a transfection internal marker and pc-myc/CDM8 and pCDM8. The total amount of DNA was kept constant in each transfection by adding the empty expression vector plasmid, pCDM8. Twenty-four hours later the medium was removed and the cells were washed once with PBS and further cultured for 6 h in DMEM supplemented with 10% FBS. Cells were then collected and analysed for luciferase activity and bgalactosidase activity. Luciferase activity was determined using PicaGene TM (ToyoInki Co Ltd) according to their instructions. Galactosidase activity was determined as described previously (Norton and Con, 1985) .
Gel retardation experiments
Gel retardation assays were performed essentially as described previously (Blackwood and Eisenman, 1991; Prendergast et al., 1991) . Recombinant GST-Myc and GST-Max were mixed and incubated for 30 min at room temperature. The mixtue was analysed for binding to a synthetic double stranded oligonucleotide encompassing a CACGTG element (MB4) of the human RCC1 gene. Double stranded oligonucleotide probe (MB4) was generated by annealing synthetic oligonucleotides tcgaT-TAGTCCACGTGTCCCG and tcgaTCGGGACACGTG-GACTAA and labelling the product with [ 32 P]dCTP using Klenow Enzyme. Final conditions within a 20 ml binding reactions were: 1 ng of 32 P-labeled MB4 oligonucleotide, 1 mg of poly(DI-dC).poly(dI-dC)(Pharmacia Biotech), 1 mg of a nonspeci®c single stranded oligonucleotide (5'-GAGTCGACGAACACACCAGGTCTTG-GAGCG), 98.5 mM NaCl, 2.1 mM KCl, 4.8 mM Sodium Phosphate, 2 mM Tris (pH 7.4), 0.1 mM EDTA and 1% glycerol. The reaction mixture was allowed to proceed at room temperature for 20 min. For antibody experiments, anity puri®ed rabbit anti Max (Oncogene Science) antibody, nonspeci®c rabbit antibody anti c-Myc monoclonal antibody (C-8) (Santa Cruz Biotechnology) or control monoclonal antibody (anti transferrin receptor monoclonal antibody Ushi) (Yoshimori et al., 1988) was added during the DNA-binding reaction. Double stranded oligonucleotides used as competitors included MB4, mMB4 (generated by annealing of tcgaTTAGTCCACCTGTCCCG and tcgaTCGGGACAGGTGGACTAA), MB5 (tcgaCG-GCCCCACGTGAAGCCC and tcgaGGGCTTCACGTG-GGGCCG), mMB5(tcgaCGGCCCCACCTGAAGCCC and tcgaGGGCTTCAGGTGGGGCCG), MB6 (tcgaTTC-GACCACGTGTGACTT and tcgaAAGTCACACGTG-GTCGAA), mMB6 (tcgaTTCGACCACCTGTGACTT and tcgaAAGTCACAGGTGGTCGAA), MB7 (tcgaG-GATTGCACGTGCAACGG and tcgaCCGTTGCACGT-GCAATCC), and mMB7 (tcgaGGATTGCACCTGCA-ACGG and tcgaCCGTTGCAGGTGCAATCC).
